Based on the latest data and analyst reviews, Groww IPO GMP (Grey Market Premium ) for the Groww IPO suggests potential listing gains. However, analysts are divided on its long-term value, with many citing high valuations.
Here is a detailed analysis based on current information.
This article is not in any sense a investment advice
📊 Current Grey Market Premium (GMP) and Listing Price Prediction
As of November 4-5, 2025, the Grey Market Premium (GMP) for the Groww IPO is ₹17. The IPO price band is set between ₹95 and ₹100 per share.
The table below shows the estimated listing price calculation based on the upper end of the price band.
| Metric | Value |
|---|---|
| IPO Price Band (per share) | ₹95 – ₹100 |
| Upper Price Band | ₹100 |
| Current GMP | ₹17 |
| Estimated Listing Price | ₹117 |
| Potential Listing Gain | ~17% |
🧐 What is the Grey Market Premium (GMP)?
The Grey Market is an unofficial market where IPO shares are traded before they are listed on stock exchanges.
- Grey Market Premium (GMP): This is the extra amount investors are willing to pay over the IPO’s issue price in this unofficial market.
- An Indicator, Not a Guarantee: A high GMP indicates strong investor interest and speculation about listing gains. However, it is not a guaranteed listing price, as the final price is determined by official market supply and demand on the listing day.
📝 Analyst Takeaways and Recommendations
Analysts have mixed views on the Groww IPO, with recommendations ranging from “Subscribe for Listing Gains” to “Neutral” for long-term investors. The table below summarizes the key analyst ratings.
| Brokerage/Analyst | Recommendation | Rationale |
|---|---|---|
| Arihant Capital | Subscribe for listing gain | Well-positioned to capture market growth; strong tech platform and profitability. |
| Anand Rathi Research | Subscribe – Long Term | Fully priced, but strengths in brand and technology support a long-term view. |
| Angel One | Neutral (Long-term perspective) | Valuation appears steep compared to peers. |
| Swastika Investmart | Subscribe (Medium-to-Long Term) | Issue seems fairly valued with limited near-term upside. |
| Bajaj Broking | Analysis provided, rating not specified | Valued at a P/E of 29.9x based on FY25 earnings. |
⚖️ Key Strengths and Risks to Consider Groww IPO GMP
✔️ Key Strengths
- Market Leadership: As of June 2025, Groww is India’s largest investment platform by active users on the NSE, with a 26.3% market share and over 12.6 million active clients.
- Strong Financial Turnaround: The company reported a net profit of ₹1,824 crore in FY25, a significant recovery from a loss of ₹805 crore in FY24.
- High Organic Growth: Over 83% of its customers are acquired organically, leading to lower marketing costs and strong brand recall.
- Scalable Technology: Its in-house tech platform handles massive scale efficiently, reducing the “Cost to Serve” from 15.9% (FY23) to 12.6% (FY24).
❗ Key Risks & Concerns
- High Valuation: At the upper price band of ₹100, the IPO is valued at a P/E ratio of 33.8x to 40.8x its FY25 earnings, which some analysts consider expensive compared to peers.
- Regulatory Dependence: The business is subject to evolving regulations. Recent SEBI changes in derivatives trading already led to a drop in active broking users.
- Revenue Concentration: A significant portion of revenue (84.5% in FY25) comes from broking services, making it vulnerable to a downturn in trading activity.


![₹444Cr or ₹254Cr? Suzlon’s Q4 Profit [2025] Puzzle Revealed Today](https://sharebaz.com/wp-content/uploads/2025/05/Add-a-heading-4_11zon-1024x576.png)
![Suzlon Stock Price Movements 29th May On Wake Of Q4 Results [2025],Expectations Broken!](https://sharebaz.com/wp-content/uploads/2025/05/Untitled-design-5_11zon-1024x576.png)

